Amy is an Assistant Professor in the Department of Epidemiology and Biostatistics at the University of Georgia. She is broadly interested in characterizing and leveraging the complex interaction between human demography and infectious disease dynamics for disease control. Her current research focuses on exploring strategies for measles and rubella control and elimination using modeling and serological data. Amy completed her PhD in Demography at Princeton University and MPH at Emory University.
She/her/hers
United States
Zambia
Madagascar
India
Ogunyemi KO, Shaikh AT, Bashir A, Dixon BE, Warmath D, Toth M, Salim J, Lokossou VK, Teferi F, Baer C, Brown J, Sogbossi LS, Zohra T, Tom-Aba D, Awori AS, Said AH, Chen Y, Antara S, Gebreyes WA, Winter AK, Ali H, Squires N, Kebede S, Asghar RJ, Chungong S, Alemu W, Aïssi MA, Sekandi JN, Wuhib T, Ohuabunwo C, Shen Y, McNabb SJN. (2026). Modernizing public health surveillance for global health security leveraging AI. Lancet regional health. Americas, (58)
Hasan AZ, Dombola AM, Prosperi C, Mufwambi W, Sakala R, Kapungu K, Chongwe G, Singh P, Wang Q, Siputuma K, Luulu M, Muchengwa MM, Sakala C, Kamiji E, Bobo P, Sakala J, Matanda K, Mwansa FD, Ward K, Winter AK, Carcelen AC, Truelove SA, Moss WJ, Mutembo S. (2026). Assessing the effectiveness of school-based vaccination checks to identify and reach un - and under-vaccinated students in Zambia. Vaccine, (79)
Drake JM, Rohani P, Winter A. (2026). Can vaccine-preventable disease resurgence be anticipated? Leading indicators and tipping points. Future microbiology
Miller SL, Billings WZ, John M, Hemme H, Atmar RL, Bernstein DI, Shen Y, Winter AK, Koelle K, Lopman BA, Handel A. (2026). Evaluation of serum antibodies as correlates of protection against norovirus infection and disease. The Journal of infectious diseases
Gaythorpe KAM, Li X, Shankar M, Hartner AM, Gibney Z, Abbas K, Abeysuriya R, Alam C, Auzenbergs M, Azman AS, Barasa E, Costello A, Ferrari MJ, Fraser K, Fu H, Haile L, Kakaï RG, Karachaliou-Prasinou A, Lee EC, Katama EN, Kim JH, Jit M, Liu Y, Malinga J, Moore S, Nayagam S, Nedjati-Gilani G, Okell LC, Onifade AA, Papadopoulos T, Penny MA, Perkins TA, Pitzer VE, Portnoy A, Procter SR, Saraswati CM, Scott N, Seaman C, Shattock AJ, Sim SY, Tran Q, Vynnycky E, Winter AK, Hinsley W, Ferguson NM, Trotter CL. (2026). Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study. Lancet, 407(10542)
Sutcliffe CG, Takahashi S, Finney AA, Hamahuwa M, Moyo N, Winter AK, Matakala HK, Muleka M, Munachoonga P, Hamangaba F, Thuma PE, Moss WJ. (2026). Timing of antiretroviral treatment initiation and seropositivity to measles virus among children living with HIV in rural Zambia. medRxiv : the preprint server for health sciences
Prosperi C, Kostandova N, Carcelen AC, Matakala KH, Bwalya IC, Musukwa G, Hamahuwa M, Mutale I, Situtu K, Chongwe G, Ndubani P, Simulundu E, Chipulu G, Musowoya J, Mwansa JK, Malambo V, Chakopo M, Hachoose C, Kabalo M, Luwaya E, Madzire A, Moyo R, Mukwengo CC, Mwansa TC, Nkoma S, Siwakwi B, Syamungulu C, Nafukwe S, Betha E, Kampamba L, Kapungu K, Matoba J, Munachoonga P, Muleka M, Mufwambi W, Vwalika S, Hasan AZ, Winter AK, Sakala C, Mwansa FD, Moss WJ, Mutembo S. (2026). Feasibility of establishing a serosurveillance system using residual specimens from district-level hospitals: A case study in Choma and Ndola Districts of Zambia. PloS one, 21(8)
Arnold CRK, Kong AC, Winter AK, Moss WJ, Patenaude BN, Ferrari MJ. (2026). Individual and population level uncertainty interact to determine the performance of outbreak surveillance systems. PLoS computational biology, 22(4)
Winter AK, Moss WJ. (2025). Measles immunity gaps and outbreak risk in a shifting landscape. The Lancet. Infectious diseases
Winter AK, Fox SJ. (2025). Measles is resurging in the Americas and the world is watching. Nature reviews. Microbiology
Powell MP, Mufwambi W, Hasan AZ, Dombola AM, Prosperi C, Sakala R, Kapungu K, Chongwe G, Singh P, Wang Q, Chewe S, Mwansa FD, Sakala C, Kamiji E, Bobo P, Matanda K, Manda J, Winter AK, Sauer M, Carcelen AC, Truelove SA, Moss WJ, Mutembo S. (2025). School Entry Vaccination Checks Allow Mapping of Under-Vaccinated Children in Zambia. Vaccines, 13(9)
Prosperi C, Truelove S, Carcelen AC, Chongwe G, Mwansa FD, Ndubani P, Simulundu E, Bwalya IC, Hamahuwa M, Kapungu K, Matakala KH, Musukwa G, Mutale I, Betha E, Chaavwa N, Kampamba L, Matoba J, Munachoonga P, Mufwambi W, Situtu K, Thuma PE, Sakala C, Kayeye P, Winter AK, Ferrari MJ, Moss WJ, Mutembo S. (2025). High measles and rubella vaccine coverage and seroprevalence among Zambian children participating in a measles and rubella supplementary immunization activity. PLOS global public health, 5(8)
Kostandova N, Prosperi C, Mutembo S, Nakazwe C, Namukoko H, Nachinga B, Lai S, Tatem AJ, Duan Q, Kabalo EN, Makungo K, Chongwe G, Chilumba I, Musukwa G, Matakala KH, Hamahuwa M, Mufwambi W, Matoba J, Mutale I, Situtu K, Simulundu E, Ndubani P, Hasan AZ, Truelove SA, Winter AK, Carcelen AC, Lau B, Moss WJ, Wesolowski A. (2025). Comparing and integrating human mobility data sources for measles transmission modeling in Zambia. PLOS global public health, 5(5)
Pilewskie M, Prosperi C, Bernasconi A, Esteban I, Niehaus L, Ross C, Carcelen AC, Moss WJ, Winter AK. (2025). The Use of Residual Blood Specimens in Seroprevalence Studies for Vaccine-Preventable Diseases: A Scoping Review. Vaccines, 13(3)
Drake JM, Bahl J, Cacciatore MA, Ghadami A, Graeden E, Han BA, Nowak G, Marty É, Robertson H, Rohani P, Sarkar S, Stott GL, Winter AK, Epureanu BI. Leveraging Systems-of-Systems Analysis to Strengthen Epidemic Intelligence for Preparedness and Response. Health security, 23(6)
Kostandova N, Mutembo S, Prosperi C, Mwansa FD, Nakazwe C, Namukoko H, Nachinga B, Chongwe G, Chilumba I, Matakala KH, Musukwa G, Hamahuwa M, Mufwambi W, Matoba J, Situtu K, Mutale I, Kong AC, Simulundu E, Ndubani P, Hasan AZ, Truelove SA, Winter AK, Carcelen AC, Lau B, Moss WJ, Wesolowski A. (2024). Who is missed in a community-based survey: Assessment and implications of biases due to incomplete sampling frame in a community-based serosurvey, Choma and Ndola Districts, Zambia, 2022. PLOS global public health, 4(4)
Carcelen AC, Prosperi C, Hamahuwa M, Kapungu K, Chongwe G, Mwansa FD, Ndubani P, Simulundu E, Bwalya IC, Matakala KH, Musukwa G, Mutale I, Betha E, Chaavwa N, Kampamba L, Matoba J, Munachoonga P, Mufwambi W, Situtu K, Thuma PE, Sakala C, Kayeye P, Truelove SA, Winter AK, Ferrari MJ, Moss WJ, Mutembo S. (2024). Feasibility and acceptability of collecting dried blood spots (DBS) from children after vaccination during supplementary immunization activities to estimate measles and rubella seroprevalence. PLOS global public health, 4(6)
Kostandova N, Prosperi C, Mutembo S, Nakazwe C, Namukoko H, Nachinga B, Chongwe G, Chilumba I, Kabalo EN, Makungo K, Matakala KH, Musukwa G, Hamahuwa M, Mufwambi W, Matoba J, Mutale I, Simulundu E, Ndubani P, Hasan AZ, Truelove SA, Winter AK, Carcelen AC, Lau B, Moss WJ, Wesolowski A. (2024). Adjusting mobile phone data to account for children's travel and the impact on measles dynamics in Zambia. American journal of epidemiology
Winter AK, Moss WJ. (2024). Possible Paths to Measles Eradication: Conceptual Frameworks, Strategies, and Tactics. Vaccines, 12(7)
Mak J, Patenaude BN, Mutembo S, Pilewskie ME, Winter AK, Moss WJ, Carcelen AC. (2024). Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies. The American journal of tropical medicine and hygiene
Prosperi C, Hasan AZ, Winter AK, Chaaithanya IK, Salvi NR, Sharma S, Bansal AK, Chauhan SL, Kulkarni RN, Lachyan A, Gawali P, Kapoor M, Shrivastava AK, Chonker SK, Bhatt V, Kaduskar O, Deshpande GR, Esteban I, Sabarinathan R, Saravana Kumar V, Truelove SA, Kumar MS, Thangaraj JWV, Sangal L, Mehendale SM, Sapkal GN, Gupta N, Hayford K, Moss WJ, Murhekar MV. (2024). Increased measles and rubella seroprevalence in children using residual blood samples from health facilities and household serosurveys after supplementary immunization activities in two districts in India. Epidemiology and infection, (152)
Moghtaderi A, Callaghan T, Luo Q, Motta M, Tan TQ, Hillard L, Dor A, Portnoy A, Winter A, Black B. (2024). Evidence on trends in uptake of childhood vaccines and association with COVID-19 vaccination rates. Vaccine, (45)
Hartner AM, Li X, Echeverria-Londono S, Roth J, Abbas K, Auzenbergs M, de Villiers MJ, Ferrari MJ, Fraser K, Fu H, Hallett T, Hinsley W, Jit M, Karachaliou A, Moore SM, Nayagam S, Papadopoulos T, Perkins TA, Portnoy A, Minh QT, Vynnycky E, Winter AK, Burrows H, Chen C, Clapham HE, Deshpande A, Hauryski S, Huber J, Jean K, Kim C, Kim JH, Koh J, Lopman BA, Pitzer VE, Tam Y, Lambach P, Sim SY, Woodruff K, Ferguson NM, Trotter CL, Gaythorpe KAM. (2024). Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study. The Lancet. Global health, 12(4)
Lambach P, Silal S, Sbarra AN, Crowcroft NS, Frey K, Ferrari M, Vynnycky E, Metcalf CJE, Winter AK, Zimmerman L, Koh M, Sheel M, Kim SY, Munywoki PK, Portnoy A, Aggarwal R, Farooqui HH, Flasche S, Hogan AB, Leung K, Moss WJ, Wang XY. (2024). Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June - 1 July 2024. Vaccine, 42(26)
Prosperi C, Hasan AZ, Winter AK, Chaaithanya IK, Salvi NR, Chauhan SL, Kulkarni RN, Lachyan A, Gawali P, Kapoor M, Bhatt V, Kaduskar O, Deshpande GR, Esteban I, Ramasamy S, Kumar VS, Truelove SA, Kumar MS, Thangaraj JWV, Sangal L, Mehendale SM, Sapkal GN, Gupta N, Hayford K, Moss WJ, Murhekar MV. (2024). Measles and rubella seroprevalence in adults using residual blood samples from health facilities and household serosurveys in Palghar District, Maharashtra, India, 2018 - 2019. Epidemiology and infection, (152)
Carcelen AC, Kong AC, Takahashi S, Hegde S, Jaenisch T, Chu M, Rochford R, Kostandova N, Gurley ES, Wesolowski A, Azman AS, van der Klis FRM, den Hartog G, Drakeley C, Heaney C, Winter AK, Salje H, Rodriguez-Barraquer I, Leung DT, Njenga SM, Kagucia EW, Jambo KC, Wolter N, Charles RC, Saboyá-Díaz MI, Martin DL, Moss WJ. (2024). Challenges and Approaches to Establishing Multi-Pathogen Serosurveillance: Findings from the 2023 Serosurveillance Summit. The American journal of tropical medicine and hygiene
Shanmugasundaram D, Viswanathan R, Winter AK, Agarwal A, Roychowdhury B, Muliyil D, Prasad GRV, Pushpalatha K, Gowda M, Singh P, Priyasree J, Bonu R, Jha S, Kumar Jena S, Jain S, Suri V, Hebbale V, Jain A, Mary Abraham A, Mishra B, Kumar Pati B, Biswas D, Pratkeye D, Ashok M, Singh MP, Dhodapkar R, Ray R, Gadepalli R, Ratho RK, Rani S, Shukla S, Ali A S, Lakshmi Nag V, Sabarinathan R, Saravana Kumar V, Priya R P, Dwibedi B, Sapkal G, Singh H, Singh K, Tiwari L, Jain M, Mondal N, Sreenivasan P, Mahantesh S, Verma S, Awasthi S, Malik S, Santhanam S, Datta S, Kumar A, Kant Chowdhary B, Khera D, Jain M, Kumar P, Pati S, Tripathi S, Murhekar M. (2024). Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022. Vaccine
Mutembo S, Yang Y, Carcelen A, Winter AK, Mwansa FD, Chilumba I, Mutale I, Chongwe G, Monze M, Mulundu G, Nkamba H, Mulenga L, Hayford K, Moss WJ. (2023). Measles immunity gaps among children and adolescents with HIV in zambia despite high measles vaccination and antiretroviral therapy coverage. AIDS (London, England)
Bolotin S, Osman S, Halperin S, Severini A, Ward BJ, Sadarangani M, Hatchette T, Pebody R, Winter A, De Melker H, Wheeler AR, Brown D, Tunis M, Crowcroft N. (2023). Immunity of Canadians and risk of epidemics workshop - Conference report. Vaccine
Yang Y, Kostandova N, Mwansa FD, Nakazwe C, Namukoko H, Sakala C, Bobo P, Masumbu PK, Nachinga B, Ngula D, Carcelen AC, Prosperi C, Winter AK, Moss WJ, Mutembo S. (2023). Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic. Vaccines, 11(3)
Winter AK, Takahashi S, Carcelen AC, Hayford K, Mutale W, Mwansa FD, Sinyange N, Ngula D, Moss WJ, Mutembo S. (2023). An evaluation of the early impact of the COVID-19 pandemic on Zambia's routine immunization program. PLOS global public health, 3(5)
Kostandova N, Loisate S, Winter A, Moss WJ, Giles JR, Metcalf CJE, Mutembo S, Wesolowski A. (2022). Impact of disruptions to routine vaccination programs, quantifying burden of measles, and mapping targeted supplementary immunization activities. Epidemics, (41)
Carcelen AC, Winter AK, Moss WJ, Chilumba I, Mutale I, Chongwe G, Monze M, Mulundu G, Nkamba H, Mwansa FD, Mulenga L, Rhoda DA, Hayford K, Mutembo S. (2022). Leveraging a national biorepository in Zambia to assess measles and rubella immunity gaps across age and space. Scientific reports, 12(1)
Winter AK, Lambert B, Klein D, Klepac P, Papadopoulos T, Truelove S, Burgess C, Santos H, Knapp JK, Reef SE, Kayembe LK, Shendale S, Kretsinger K, Lessler J, Vynnycky E, McCarthy K, Ferrari M, Jit M. (2022). Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study. The Lancet. Global health, 10(10)
Murhekar MV, Gupta N, Hasan AZ, Kumar MS, Kumar VS, Prosperi C, Sapkal GN, Thangaraj JWV, Kaduskar O, Bhatt V, Deshpande GR, Thankappan UP, Bansal AK, Chauhan SL, Grover GS, Jain AK, Kulkarni RN, Sharma SK, Chaaithanya IK, Kharwal S, Mishra SK, Salvi NR, Sharma S, Sarmah NP, Sabarinathan R, Duraiswamy A, Rani DS, Kanagasabai K, Lachyan A, Gawali P, Kapoor M, Shrivastava AK, Chonker SK, Tilekar B, Tandale BV, Ahmad M, Sangal L, Winter A, Mehendale SM, Moss WJ, Hayford K. (2022). Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020. The Lancet. Global health, 10(11)
Winter AK, Moss WJ. (2022). Rubella. Lancet, 399(10332)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.